The genome-wide DNA sequence specificity of the anti-tumour drug bleomycin in human cells (Q39759582)

14 September 2017

title

The genome-wide DNA sequence specificity of the anti-tumour drug bleomycin in human cells (English)

1 reference

14 September 2017

Vincent Murray

1

1 reference

14 September 2017

Jon K Chen

series ordinal

2

1 reference

14 September 2017

Mark M Tanaka

series ordinal

3

1 reference

14 September 2017

publication date

17 May 2016

1 reference

Molecular Biology Reports

14 September 2017

published in

1 reference

14 September 2017

volume

43

1 reference

14 September 2017

issue

7

1 reference

14 September 2017

page(s)

639-651

1 reference

Curing metastatic testicular cancer

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Quantitative measurement of single- and double-strand breakage of DNA in Escherichia coli by the antitumor antibiotics bleomycin and talisomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Structure of bleomycin-induced DNA double-strand breaks: predominance of blunt ends and single-base 5' extensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Bleomycins: towards better therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Selective tumor cell targeting by the disaccharide moiety of bleomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

The disaccharide moiety of bleomycin facilitates uptake by cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Interaction of bleomycin with DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Strand-scission of DNA by neocarzinostatin, auromomycin, and bleomycin: studies on base release and nucleotide sequence specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Sequence specific cleavage of DNA by the antitumor antibiotics neocarzinostatin and bleomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Specificity of deoxyribonucleic acid cleavage by bleomycin, phleomycin, and tallysomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Comparison of the sequence specificity of bleomycin cleavage in two slightly different DNA sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

DNA structure influences sequence specific cleavage by bleomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Human telomeric DNA sequences are a major target for the antitumour drug bleomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

The mitochondrial DNA sequence specificity of the anti-tumour drug bleomycin using end-labeled DNA and capillary electrophoresis and a comparison with genome-wide DNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

The determination of the DNA sequence specificity of bleomycin-induced abasic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

The DNA sequence specificity of bleomycin cleavage in telomeric sequences in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Influence of chromatin structure on bleomycin-DNA interactions at base pair resolution in the human beta-globin gene cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Chromatin structure at the 3'-boundary of the human beta-globin locus control region hypersensitive site-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Genomic and phylogenetic footprinting at the epsilon-globin silencer region in intact human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Footprinting the 'essential regulatory region' of the retinoblastoma gene promoter in intact human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Bleomycin causes release of nucleosomes from chromatin and chromosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

The influence of chromatin structure on DNA damage induced by nitrogen mustard and cisplatin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Characterization of bleomycin-mediated cleavage of a hairpin DNA library.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

A short DNA sequence confers strong bleomycin binding to hairpin DNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

DNA methylation reduces binding and cleavage by bleomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

The use of automated sequencing techniques to investigate the sequence selectivity of DNA-damaging agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Accurate whole human genome sequencing using reversible terminator chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Next-generation DNA sequencing methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Genome-wide analysis of the relationships between DNaseI HS, histone modifications and gene expression reveals distinct modes of chromatin domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Opening Pandora's Box--the new biology of driver mutations and clonal evolution in cancer as revealed by next generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Next-generation sequencing: The genome jigsaw

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Genome-wide nucleosome specificity and function of chromatin remodellers in ES cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

The anti-tumor drug bleomycin preferentially cleaves at the transcription start sites of actively transcribed genes in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Ultrafast and memory-efficient alignment of short DNA sequences to the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

The Sequence Alignment/Map format and SAMtools

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

DNA methylation landscapes: provocative insights from epigenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

An investigation of the sequence-specific interaction of cis-diamminedichloroplatinum(II) and four analogues, including two acridine-tethered complexes, with DNA inside human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

The interaction of DNA-targeted 9-aminoacridine-4-carboxamide platinum complexes with DNA in intact human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Crystal structure of the nucleosome core particle at 2.8 Å resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

DNA stretching and extreme kinking in the nucleosome core

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Robust Regression and Outlier Detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-016-3998-7

Cleavage of Nucleic Acids by Bleomycin

21 January 2018

1 reference

12 December 2020

The sequence specificity of bleomycin damage in three cloned DNA sequences that differ by a small number of base substitutions.

1 reference

12 December 2020

A survey of the sequence-specific interaction of damaging agents with DNA: emphasis on antitumor agents.

1 reference

12 December 2020

A large "footprint" at the boundary of the human beta-globin locus control region hypersensitive site-2.

1 reference

12 December 2020

Bleomycin-induced strand-scission of DNA. Mechanism of deoxyribose cleavage

1 reference

12 December 2020

Next generation sequencing technologies in cancer diagnostics and therapeutics: A mini review

1 reference

12 December 2020

Bleomycin and talisomycin sequence-specific strand scission of DNA: a mechanism of double-strand cleavage

1 reference

12 December 2020

New antibiotics, bleomycin A and B

1 reference

12 December 2020

Origin of malondialdehyde from DNA degraded by Fe(II) x bleomycin

1 reference

12 December 2020

Mechanics of sequence-dependent stacking of bases in B-DNA

1 reference

12 December 2020

The sequence specificity of bleomycin-induced DNA damage in intact cells

1 reference

12 December 2020

Biochemical and cellular determinants of bleomycin cytotoxicity

1 reference

12 December 2020

The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma

1 reference

12 December 2020

Enhanced DNA repair of bleomycin-induced 3'-phosphoglycolate termini at the transcription start sites of actively transcribed genes in human cells

1 reference

12 December 2020

10.1007/S11033-016-3998-7

Identifiers

DOI

1 reference

14 September 2017

1 reference